The role of IRES trans-acting factors in carcinogenesis.

Regulation of protein expression through RNA metabolism is a key aspect of cellular homeostasis. Upon specific cellular stresses, distinct transcripts are selectively controlled to modify protein output in order to quickly and appropriately respond to stress. Reprogramming of the translation machinery is one node of this strict control that typically consists of an attenuation of the global, cap-dependent translation and accompanying switch to alternative mechanisms of translation initiation, such as internal ribosome entry site (IRES)-mediated initiation. In cancer, many aspects of the RNA metabolism are frequently misregulated to provide cancer cells with a growth and survival advantage. This includes changes in the expression and function of RNA binding proteins termed IRES trans-acting factors (ITAFs) that are central to IRES translation. In this review, we will examine select emerging, as well as established, ITAFs with important roles in cancer initiation and progression, and in particular their role in IRES-mediated translation. This article is part of a Special Issue entitled: Translation and Cancer.

[1]  K. Masuda,et al.  NF90 in Posttranscriptional Gene Regulation and MicroRNA Biogenesis , 2013, International journal of molecular sciences.

[2]  M. Bushell,et al.  Canonical Initiation Factor Requirements of the Myc Family of Internal Ribosome Entry Segments , 2009, Molecular and Cellular Biology.

[3]  F. Nielsen,et al.  A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development , 1999, Molecular and Cellular Biology.

[4]  Neil J. Sebire,et al.  FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2 , 2006 .

[5]  S. Ralston,et al.  A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation , 2000, Oncogene.

[6]  A. Kimchi,et al.  The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Gu,et al.  Blocking β-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells , 2009, Journal of Cell Science.

[8]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[9]  J. Avruch,et al.  mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts. , 2013, Genes & development.

[10]  K. Phoenix,et al.  Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis , 2007, Molecular and Cellular Biology.

[11]  H. Bonkovsky,et al.  Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery. , 2011, Journal of proteome research.

[12]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[13]  Wei Li,et al.  Anthrax lethal toxin paralyzes actin‐based motility by blocking Hsp27 phosphorylation , 2007, The EMBO journal.

[14]  Stefan Hüttelmaier,et al.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? , 2012, Cellular and Molecular Life Sciences.

[15]  D. Hernandez-Verdun,et al.  Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function , 2006, Retrovirology.

[16]  S. Formenti,et al.  Translational control in cancer , 2010, Nature Reviews Cancer.

[17]  Sun-Mi Park,et al.  Let‐7 modulates acquired resistance of ovarian cancer to Taxanes via IMP‐1‐mediated stabilization of multidrug resistance 1 , 2012, International journal of cancer.

[18]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[19]  A. Komar,et al.  A new framework for understanding IRES-mediated translation. , 2012, Gene.

[20]  A. Kimchi,et al.  The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA , 2014, Oncogene.

[21]  N. Sebire,et al.  FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. , 2006, The EMBO journal.

[22]  A E Willis,et al.  Translation inhibition during the induction of apoptosis: RNA or protein degradation? , 2004, Biochemical Society transactions.

[23]  M. Holcik,et al.  The translation of an antiapoptotic protein HIAP2 is regulated by an upstream open reading frame , 2003, Cell Death and Differentiation.

[24]  E. Wahle,et al.  Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. , 2008, RNA.

[25]  Yi Wen Kong,et al.  Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. , 2006, Molecular cell.

[26]  H. Ngan,et al.  Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer , 2012, PloS one.

[27]  M. Bushell,et al.  Translational regulation of gene expression during conditions of cell stress. , 2010, Molecular cell.

[28]  Amber L. Wells,et al.  Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ZBP1 , 2012, Journal of Cell Science.

[29]  N. Sonenberg,et al.  The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.

[30]  Hoong-Chien Lee,et al.  ToP: A Trend-of-Disease-Progression Procedure Works Well for Identifying Cancer Genes from Multi-State Cohort Gene Expression Data for Human Colorectal Cancer , 2013, PloS one.

[31]  M. Mathews,et al.  NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response , 2010, Cell Death and Differentiation.

[32]  A. Antsaklis,et al.  CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells* , 2005, Journal of Biological Chemistry.

[33]  P. Schirmacher,et al.  Insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma , 2014, Hepatology.

[34]  M. Clemens,et al.  Initiation factor modifications in the preapoptotic phase , 2005, Cell Death and Differentiation.

[35]  K. Klempnauer,et al.  A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation , 2014, Oncogene.

[36]  N. Colburn,et al.  Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.

[37]  N. Sonenberg,et al.  Internal ribosome initiation of translation and the control of cell death. , 2000, Trends in genetics : TIG.

[38]  O. Pardo,et al.  Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2 , 2012, Molecular and Cellular Biology.

[39]  H. Kawasaki,et al.  Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. , 1998, Cancer research.

[40]  M. Holcik,et al.  Translation control in apoptosis. , 2012, Experimental oncology.

[41]  S. Hüttelmaier,et al.  IGF2BP1: a post-transcriptional "driver" of tumor cell migration. , 2012, Cell adhesion & migration.

[42]  T. Hansen,et al.  Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice , 2004, Molecular and Cellular Biology.

[43]  Yi Guo,et al.  Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. , 2011, Oncology reports.

[44]  R. Singer,et al.  Characterization of a beta-actin mRNA zipcode-binding protein , 1997, Molecular and cellular biology.

[45]  M. Gorospe,et al.  NF90 coordinately represses the senescence-associated secretory phenotype , 2012, Aging.

[46]  Alain C. Mita,et al.  Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics , 2008, Clinical Cancer Research.

[47]  R. Shiekhattar,et al.  The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.

[48]  F. McCormick,et al.  p97/DAP5 is a ribosome‐associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins , 2006, The EMBO journal.

[49]  T. Triche,et al.  Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. , 2009, Cancer cell.

[50]  N. Guo,et al.  Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. , 2009, Lung cancer.

[51]  Zijie Sun,et al.  Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both β-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells , 2008, Oncogene.

[52]  H. Allgayer,et al.  Down-regulation of E-cadherin is an essential event in activating β-catenin/Tcf dependent transcription and expression of its target genes in Pdcd4 knock-down cells , 2009, Oncogene.

[53]  Charles R. Tessier,et al.  Mammary Tumor Induction in Transgenic Mice Expressing an RNA-Binding Protein , 2004, Cancer Research.

[54]  V. Speirs,et al.  Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity , 2009, British Journal of Cancer.

[55]  R. Singer,et al.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. , 2012, Genes & development.

[56]  S. M. Lewis,et al.  Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells , 2013, Oncogene.

[57]  Vishva M. Dixit,et al.  IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.

[58]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[59]  Chow H Lee,et al.  CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease , 2007, Nucleic acids research.

[60]  R. Fåhraeus,et al.  Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation , 2006, Oncogene.

[61]  D. Chan,et al.  DNA-dependent Protein Kinase Interacts with Antigen Receptor Response Element Binding Proteins NF90 and NF45* , 1998, The Journal of Biological Chemistry.

[62]  R. Grover,et al.  Two internal ribosome entry sites mediate the translation of p53 isoforms , 2006, EMBO reports.

[63]  J. Avruch,et al.  mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. , 2011, Genes & development.

[64]  U. Dafni,et al.  Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer , 2007, International journal of cancer.

[65]  M. Mathews,et al.  Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells , 2012, Oncogene.

[66]  Xuan Pan,et al.  MicroRNA-21: A novel therapeutic target in human cancer , 2010, Cancer biology & therapy.

[67]  N. Colburn,et al.  Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression , 2009, Breast Cancer Research and Treatment.

[68]  A. Rustgi,et al.  IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. , 2013, Carcinogenesis.

[69]  S. Hyberts,et al.  PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains , 2008, Proceedings of the National Academy of Sciences.

[70]  J. Graff,et al.  Targeting the eukaryotic translation initiation factor 4E for cancer therapy. , 2008, Cancer research.

[71]  S. Hauptmann,et al.  Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma , 2007, Oncogene.

[72]  N. Colburn,et al.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Kimchi,et al.  The translation initiation factor DAP5 is a regulator of cell survival during mitosis , 2009, Cell cycle.

[74]  Yong Huang,et al.  MicroRNA-21 gene and cancer , 2013, Medical Oncology.

[75]  M. Mathews,et al.  The NF90/NF45 Complex Participates in DNA Break Repair via Nonhomologous End Joining , 2011, Molecular and Cellular Biology.

[76]  M. Gorospe,et al.  NF90 selectively represses the translation of target mRNAs bearing an AU-rich signature motif , 2009, Nucleic acids research.

[77]  L. Gehrke,et al.  NF90 Binds the Dengue Virus RNA 3′ Terminus and Is a Positive Regulator of Dengue Virus Replication , 2011, PloS one.

[78]  M. Holcik,et al.  For IRES trans-acting factors, it is all about location , 2008, Oncogene.

[79]  Shuang Huang,et al.  Interleukin Enhancer-Binding Factor 3 Promotes Breast Tumor Progression by Regulating Sustained Urokinase-Type Plasminogen Activator Expression , 2012, Oncogene.

[80]  Stefan Hüttelmaier,et al.  IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG) , 2013, Nucleic acids research.

[81]  M. Gromeier,et al.  The Double-Stranded RNA Binding Protein 76:NF45 Heterodimer Inhibits Translation Initiation at the Rhinovirus Type 2 Internal Ribosome Entry Site , 2006, Journal of Virology.

[82]  M. Mathews,et al.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.

[83]  Sonia Cerquozzi,et al.  Translational Induction of the Inhibitor of Apoptosis Protein HIAP2 during Endoplasmic Reticulum Stress Attenuates Cell Death and Is Mediated via an Inducible Internal Ribosome Entry Site Element* , 2004, Journal of Biological Chemistry.

[84]  R. Korneluk,et al.  Modulation of immune signalling by inhibitors of apoptosis. , 2012, Trends in immunology.

[85]  E. Hatano,et al.  The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway , 2009, Molecular and Cellular Biology.

[86]  John S. Condeelis,et al.  Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.

[87]  D. Ruggero.  Translational control in cancer etiology. , 2012, Cold Spring Harbor perspectives in biology.

[88]  Amber L. Wells,et al.  Feedback Regulation between Zipcode Binding Protein 1 and β-Catenin mRNAs in Breast Cancer Cells , 2008, Molecular and Cellular Biology.

[89]  J. Houghton,et al.  Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[90]  J. L. Quesne,et al.  C-Myc 5′ untranslated region contains an internal ribosome entry segment , 1998, Oncogene.

[91]  P. Brown,et al.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Mark J. Bowser,et al.  IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. , 2011, Cancer research.

[93]  Robert V Farese,et al.  Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway , 2000, The EMBO journal.

[94]  T. Honjo,et al.  Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. , 1995, Gene.

[95]  R. Carmody,et al.  DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. , 2002, Biochemical and biophysical research communications.

[96]  R. Häsler,et al.  Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells. , 2014, Gastroenterology.

[97]  M. Carr,et al.  Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation , 2011, Oncogene.

[98]  B. Semler,et al.  Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. , 2009, Biochimica et biophysica acta.

[99]  Tobias Schmid,et al.  Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. , 2008, Cancer research.

[100]  M J Clemens,et al.  Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells , 2000, Cell Death and Differentiation.

[101]  N. Sonenberg,et al.  Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.

[102]  O. Elroy-Stein,et al.  DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. , 2008, Molecular cell.

[103]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[104]  M. Holcik,et al.  The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress , 2007, Nucleic acids research.

[105]  M. Bushell,et al.  Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1 , 2010, Oncogene.

[106]  A. Smith,et al.  Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. , 1994, The Journal of biological chemistry.

[107]  F. Nielsen,et al.  RNA‐binding IMPs promote cell adhesion and invadopodia formation , 2006, The EMBO journal.

[108]  K. Klempnauer,et al.  Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA* , 2011, The Journal of Biological Chemistry.

[109]  A. Wlodawer,et al.  Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4 , 2006, Molecular and Cellular Biology.

[110]  N. Sonenberg,et al.  mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.

[111]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[112]  D. Selinger,et al.  Identification of Cardiac Glycoside Molecules as Inhibitors of c-Myc IRES-Mediated Translation , 2013, Journal of biomolecular screening.

[113]  K. Klempnauer,et al.  siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression , 2008, Oncogene.

[114]  E. Perlman,et al.  Insights on neoplastic stem cells from gel‐based proteomics of childhood germ cell tumors , 2012, Pediatric blood & cancer.

[115]  M. Holcik,et al.  Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation , 2013, Oncotarget.

[116]  H. Miyoshi,et al.  Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. , 2012, Gastroenterology.

[117]  V. Spiegelman,et al.  Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents , 2012, Pigment cell & melanoma research.

[118]  S. Baird,et al.  Nucleotide Composition of Cellular Internal Ribosome Entry Sites Defines Dependence on NF45 and Predicts a Posttranscriptional Mitotic Regulon , 2012, Molecular and Cellular Biology.

[119]  M. Halaby,et al.  The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage , 2006, Oncogene.

[120]  R. Göke,et al.  The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation , 2009, Biology of the cell.

[121]  R. Korneluk,et al.  IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1 , 2014, Oncogene.

[122]  M. Bushell,et al.  Internal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors , 2005, Cell Death and Differentiation.

[123]  J. Condeelis,et al.  Spatial regulation of β-actin translation by Src-dependent phosphorylation of ZBP1 , 2005, Nature.

[124]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[125]  Yong Li,et al.  Chinese Anti鄄 Cancer a Ssociation , 2022 .

[126]  M. Hentze,et al.  Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[127]  T. Innerarity,et al.  A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. , 1997, Genes & development.

[128]  R. Korneluk,et al.  Distinct Regulation of Internal Ribosome Entry Site-mediated Translation following Cellular Stress Is Mediated by Apoptotic Fragments of eIF4G Translation Initiation Factor Family Members eIF4GI and p97/DAP5/NAT1* , 2003, The Journal of Biological Chemistry.

[129]  Qifeng Yang,et al.  Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice. , 2013, European journal of cancer.

[130]  K. Kawakami,et al.  Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. , 2009, Cancer research.

[131]  Nahum Sonenberg,et al.  A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A , 2004, Molecular and Cellular Biology.

[132]  A. Zetterberg,et al.  What is the restriction point? , 1995, Current opinion in cell biology.

[133]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[134]  Jonathan R Warner,et al.  What better measure than ribosome synthesis? , 2004, Genes & development.

[135]  P. Hainaut,et al.  ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 , 2002, Oncogene.

[136]  Michael B. Mathews,et al.  Nuclear Factor 45 (NF45) Is a Regulatory Subunit of Complexes with NF90/110 Involved in Mitotic Control , 2008, Molecular and Cellular Biology.

[137]  I. Lemm,et al.  Regulation of c-myc mRNA Decay by Translational Pausing in a Coding Region Instability Determinant , 2002, Molecular and Cellular Biology.

[138]  M. Bushell,et al.  Re‐programming of translation following cell stress allows IRES‐mediated translation to predominate , 2008, Biology of the cell.

[139]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.